Evidence map›Paper›PMID 38343853›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival.

Scott M Matson, Linh T Ngo, Yui Sugawara, Veani Fernando, Claudia Lugo, Imaan Azeem, Alexis Harrison, Alex Alsup, Emily Nissen, Devin Koestler and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Scott M MatsonDivision of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
Linh T NgoDivision of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
Yui SugawaraDepartment of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
Veani FernandoDivision of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
Claudia LugoDivision of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
Imaan AzeemDivision of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
Alexis HarrisonDivision of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
Alex AlsupDepartment of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
Emily NissenDepartment of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
Devin KoestlerDepartment of Biostatistics & Data Science, University of Kansas School of Medicine, Kansas City, KS, USA.
Michael P WashburnDepartment of Cancer Biology, University of Kansas School of Medicine, Kansas City, KS, USA.ORCID 0000-0001-7568-2585
Michaella J RekowskiDepartment of Cancer Biology, University of Kansas School of Medicine, Kansas City, KS, USA.
Paul J WoltersDivision of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA.
Joyce S LeeDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, USA.
Joshua J SolomonDivision of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health Hospital, Denver, CO.
M Kristen DemoruelleDivision of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
University of Kansas · USUniversity of Colorado Denver · USThe University of Kansas Cancer Center · USNational Jewish Health · USToranomon Hospital · JPUniversity of California, San Francisco · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Kalyani Pyaram, Steven Allan Soper · 2019 to 2026
$21.5M
Neutrophil Extracellular Traps in the Lung and Development of Rheumatoid Arthritis-Related Autoimmunity and ArthritisR01AR076450 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI DEMORUELLE, M. KRISTEN · 2020 to 2024
$2.7M
NCI NIH HHS P30 CA168524NIAMS NIH HHS R01 AR076450NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) leads to progressive loss of lung function and mortality. Understanding mechanisms and markers of lung injury in IPF is paramount to improving outcomes for these patients. Despite the lack of systemic involvement in IPF, many analyses focus on identifying Methods: In our discovery analysis, agnostic label-free quantitative proteomics differentiated lung tissue protein expression based on survival trajectory (n=10). Following selection of the candidate pathway (neutrophil extracellular trap (NET) formation), we subsequently validated the presence of NETs in the IPF lung microenvironment using fully quantitative assays of known NET remnants in separate IPF cohorts (n=156 and n=52) with bronchoalveolar lavage fluid. We then assessed the correlation of these markers with baseline pulmonary function and survival. Results: Discovery lung tissue proteomics identified NET formation as significantly associated with poor IPF survival. Using fully quantitative confirmatory tests for reproducibility we confirmed the presence of NET markers in IPF BALF and found significant correlations with worse pulmonary function in both cohorts (p<0.03 and p = 0.04 respectively). In the survival cohort, higher levels of NET markers predicted worse survival after adjusting for gender, age, and baseline physiologic severity (hazard ratio range: 1.79-2.19). Conclusions: NET markers were associated with disease severity and worse survival in IPF. These findings suggest NET formation contributes to lung injury and decreased survival in IPF and may represent a potential therapeutic target.

Identifiers

PMID38343853
PMCPMC10854325
OpenAlexW4391213661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.